Type and Press enter

ORIGINATORS

Originators are developed after many years of laboratory and clinical research and they are subject to strict regulations that ensure their quality, safety and effectiveness.

TRADE NAME ACTIVE INGREDIENT THERAPEUTIC CLASSIFICATION

The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).


GENERICS

Providing safe generics gives patients who would not be able to buy the originator, access to effective treatment, while it saves a great amount of money for the national health system and releases the resources for more expensive treatments.

READ MORE
TRADE NAME ACTIVE INGREDIENT THERAPEUTIC CLASSIFICATION
Londer Anastrozole Endocrine treatment
Gemcipen Gemcitabine Hydrochloride Antineoplastic drug
Letropen Letrozole Endocrine treatment
Ridoca Temozolomide Antineoplastic drug
Imatinib / Aenorasis Imatinib Oncology, Haematology
Voriconazole / Aenorasis Voriconazole

The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).


BIOSIMILARS

Introducing Biosimilars in the international pharmaceutical market improves patients' access to effective treatments, it allows the medical community to provide cost-effective choices and it reduces significantly the total cost of treatment and of the total pharmaceutical expenditure.

Under Construction